Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis.

Increased nasal airflow resistance (NAR) may contribute to the pathophysiology of obstructive sleep apnoea syndrome (OSAS) but studies investigating the effects of relieving nasal obstruction in OSAS have produced differing results. There are no reports of intranasal corticosteroid therapy in adult OSAS patients with reversible nasal obstruction.We evaluated an intranasal corticosteroid, fluticasone propionate, in 24 consecutive snorers with...